Cargando…
Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis
Gait disorders are one of the leading patient complaints at the sub-acute stroke stage (SSS) and a main determinant of disability. Walking speed (WS) is a major vital and functional index, and the Ten-Meter Walk Test is considered the gold standard after stroke. Based on a systematic review of the l...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549366/ https://www.ncbi.nlm.nih.gov/pubmed/36226075 http://dx.doi.org/10.3389/fneur.2022.989622 |
_version_ | 1784805653697527808 |
---|---|
author | Tasseel-Ponche, Sophie Delafontaine, Arnaud Godefroy, Olivier Yelnik, Alain P. Doutrellot, Pierre-Louis Duchossoy, Charline Hyra, Marie Sader, Thibaud Diouf, Momar |
author_facet | Tasseel-Ponche, Sophie Delafontaine, Arnaud Godefroy, Olivier Yelnik, Alain P. Doutrellot, Pierre-Louis Duchossoy, Charline Hyra, Marie Sader, Thibaud Diouf, Momar |
author_sort | Tasseel-Ponche, Sophie |
collection | PubMed |
description | Gait disorders are one of the leading patient complaints at the sub-acute stroke stage (SSS) and a main determinant of disability. Walking speed (WS) is a major vital and functional index, and the Ten-Meter Walk Test is considered the gold standard after stroke. Based on a systematic review of the literature, studies published between January 2000 and November 2021 were selected when WS was reported (ten-meter walk test for short distance and/or 6-min walking distance for long distance) within 6 months following a first ischemic and/or hemorrhagic stroke (SSS) in adults prior to receiving specific walking rehabilitation. Following PRISMA guidelines, a meta-analysis was conducted on two kinds of WS: the principal criterion focused on short-distance WS (ten-meter walking test) and the secondary criteria focused on long-distance WS (6-min test) and meta-regressions to study the association of WS with balance, cognitive disorders and autonomy. Nine studies comprising a total of 939 data on post-stroke patients were selected. The weighted average age was 61 years [95% IC [55-67] and males represented 62% ± 2.7 of patients [57-67]. Average short-distance WS was 0.36 ± 0.06 m.s(−1) [95% CI (0.23–0.49)]. Average long-distance WS was 0.46 ± 0.1 m.s(−1) [95% CI (0.26–0.66)]. The funnel plot revealed asymmetry of publication bias and high heterogeneity of the nine studies (I(2) index 98.7% and Q-test p < 0.0001). Meta-regressions of secondary endpoints could not be performed due to a lack of study data. At the SSS, WS would be lower than data in general population published in literature, but above all, lower than the WS required for safe daily autonomy and community ambulation after stroke. WS must be a priority objective of stroke rehabilitation to increase walking function but also for survival, autonomy, social participation and health-related quality of life. |
format | Online Article Text |
id | pubmed-9549366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95493662022-10-11 Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis Tasseel-Ponche, Sophie Delafontaine, Arnaud Godefroy, Olivier Yelnik, Alain P. Doutrellot, Pierre-Louis Duchossoy, Charline Hyra, Marie Sader, Thibaud Diouf, Momar Front Neurol Neurology Gait disorders are one of the leading patient complaints at the sub-acute stroke stage (SSS) and a main determinant of disability. Walking speed (WS) is a major vital and functional index, and the Ten-Meter Walk Test is considered the gold standard after stroke. Based on a systematic review of the literature, studies published between January 2000 and November 2021 were selected when WS was reported (ten-meter walk test for short distance and/or 6-min walking distance for long distance) within 6 months following a first ischemic and/or hemorrhagic stroke (SSS) in adults prior to receiving specific walking rehabilitation. Following PRISMA guidelines, a meta-analysis was conducted on two kinds of WS: the principal criterion focused on short-distance WS (ten-meter walking test) and the secondary criteria focused on long-distance WS (6-min test) and meta-regressions to study the association of WS with balance, cognitive disorders and autonomy. Nine studies comprising a total of 939 data on post-stroke patients were selected. The weighted average age was 61 years [95% IC [55-67] and males represented 62% ± 2.7 of patients [57-67]. Average short-distance WS was 0.36 ± 0.06 m.s(−1) [95% CI (0.23–0.49)]. Average long-distance WS was 0.46 ± 0.1 m.s(−1) [95% CI (0.26–0.66)]. The funnel plot revealed asymmetry of publication bias and high heterogeneity of the nine studies (I(2) index 98.7% and Q-test p < 0.0001). Meta-regressions of secondary endpoints could not be performed due to a lack of study data. At the SSS, WS would be lower than data in general population published in literature, but above all, lower than the WS required for safe daily autonomy and community ambulation after stroke. WS must be a priority objective of stroke rehabilitation to increase walking function but also for survival, autonomy, social participation and health-related quality of life. Frontiers Media S.A. 2022-09-26 /pmc/articles/PMC9549366/ /pubmed/36226075 http://dx.doi.org/10.3389/fneur.2022.989622 Text en Copyright © 2022 Tasseel-Ponche, Delafontaine, Godefroy, Yelnik, Doutrellot, Duchossoy, Hyra, Sader and Diouf. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Tasseel-Ponche, Sophie Delafontaine, Arnaud Godefroy, Olivier Yelnik, Alain P. Doutrellot, Pierre-Louis Duchossoy, Charline Hyra, Marie Sader, Thibaud Diouf, Momar Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis |
title | Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis |
title_full | Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis |
title_fullStr | Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis |
title_full_unstemmed | Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis |
title_short | Walking speed at the acute and subacute stroke stage: A descriptive meta-analysis |
title_sort | walking speed at the acute and subacute stroke stage: a descriptive meta-analysis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549366/ https://www.ncbi.nlm.nih.gov/pubmed/36226075 http://dx.doi.org/10.3389/fneur.2022.989622 |
work_keys_str_mv | AT tasseelponchesophie walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT delafontainearnaud walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT godefroyolivier walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT yelnikalainp walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT doutrellotpierrelouis walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT duchossoycharline walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT hyramarie walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT saderthibaud walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis AT dioufmomar walkingspeedattheacuteandsubacutestrokestageadescriptivemetaanalysis |